跳至主要内容
临床试验/NCT06986629
NCT06986629招募中不适用

Effect of Photobiostimulation Versus Pulsed Electromagnetic Field on Quality of Life in Adults With Chronic Rhinosinusitis

Cairo University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
assessment of change of quality of life

研究概览

简要总结

This study was done to find out the effect of photobiostimulation and pulsed electromagnetic field in patients with chronic rhinosinusitis on:

  • Quality of life.
  • Pulmonary function.
  • Mean platelet volume.
  • headache .
  • total nasal symptoms.

详细描述

Chronic rhinosinusitis is a severe disease that significantly impacts a patient's quality of life, leading to significant economic impacts on healthcare resources and absenteeism. Symptoms interfere with daily activities and can lead to medication resistance. Treatment options like steroids, oral antibiotics, and sinus surgery are less effective, and disease recurrence remains high even after surgery. Alternative therapies like low-level laser therapy and pulsed electromagnetic filed have shown promise in improving symptoms and potentially making low-level laser therapy a non-invasive treatment for Chronic rhinosinusitis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 40 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Participants suffering from mild to moderate symptoms (baseline Total nasal symptoms score ≤ 9).
  • •Subjects age range from 20 to 40 years old.
  • •Patients of both sexes.
  • •proven positive allergy test (skin prick test or multiple allergen simultaneous test) to any of the common perennial allergens such as dust mites, molds, insects, and animal dander within the last 12 months

排除标准

  • •Pregnant or breastfeeding women.
  • •Patients with a definite deviated nasal septum, or history of operation within the last 6 months.
  • •Hypertension, diabetes mellitus, malignancy, active pulmonary tuberculosis, active respiratory disease like asthma, or other systemic diseases.
  • •Long-term use of corticosteroids or immunosuppressive agents.
  • •Participation in another clinical study within 30 days.
  • •Hyperthyroidism
  • •Patients who had used antihistamines within 1 week, topical corticosteroids within 2 weeks, systemic corticosteroids within 4 weeks, anticholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, nonsteroidal analgesics within 2 weeks, and other drugs that the researchers believed were inappropriate.
  • •Patients with Tattoos, moles and dark skin

研究组 & 干预措施

pulsed electromagnetic therapy

Experimental

This group included twenty adults with chronic rhinosinusitis and received pulsed electromagnetic therapy. This treatment protocol will be carried out three times per week for 8 weeks

干预措施: pulsed electromagnetic therapy (Device)

Photobiostimulation

Active Comparator

This group included twenty adults with chronic rhinosinusitis and received low level laser therapy. This treatment protocol will be carried out three times per week for 8 weeks

干预措施: Photobiostimulation (Device)

Self-sinus massage technique

Active Comparator

This group included twenty adults with chronic rhinosinusitis and received the self-sinus massage technique only. This treatment protocol will be carried out three times per week for 8 weeks

干预措施: Self-sinus massage technique (Other)

结局指标

主要结局

assessment of change of quality of life

时间窗: at baseline and after 8 weeks

The Sinonasal Outcome Test-22 questionnaire is a commonly used tool in clinical practice to assess patients' quality of life with chronic respiratory syndrome. It consists of 22 chronic respiratory syndrome-related items, ranging from 0 to 5, and categorizes them into physical symptoms (items 1-12) and health and quality of life (items 13-22), covering sleep function and psychological difficulties. It is easy to understand and complete.

次要结局

  • assessment of change of Mean platelet volume(at baseline and after 8 weeks)
  • assessment of change of headache pain severity(at baseline and after 8 weeks)
  • assessment of change of white blood cells count(at baseline and after 8 weeks)
  • assessment of change of pulmonary functions(at baseline and after 8 weeks)
  • assessment of change of total nasal symptoms(at baseline and after 8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Samar Said Abd Al-Razek Abd Al-Fattah

principal investigator

Cairo University

研究点 (1)

Loading locations...

相似试验